Industry: Medical Devices & Consumables
Published Date: 2024-06-11
Pages: 135 Pages
Report ld: 3193797
Request Sample
Customized Report
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
The global Implantable Heart Failure Devices revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Implantable Heart Failure Devices revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Implantable Heart Failure Devices market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Implantable Heart Failure Devices include Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, etc. The global five biggest players hold a share of % in 2023.
Implantable Heart Failure Devices market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Implantable Heart Failure Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Implantable Heart Failure Devices market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Implantable Heart Failure Devices definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Implantable Heart Failure Devices companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Implantable Heart Failure Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Implantable Heart Failure Devices sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Implantable Heart Failure Devices Product Introduction
1.2 Global Implantable Heart Failure Devices Outlook 2019 VS 2023 VS 2030
1.2.1 Global Implantable Heart Failure Devices Sales in US$ Million for the Year 2019-2030
1.2.2 Global Implantable Heart Failure Devices Sales in Volume for the Year 2019-2030
1.3 United States Implantable Heart Failure Devices Outlook 2019 VS 2023 VS 2030
1.3.1 United States Implantable Heart Failure Devices Sales in US$ Million for the Year 2019-2030
1.3.2 United States Implantable Heart Failure Devices Sales in Volume for the Year 2019-2030
1.4 Implantable Heart Failure Devices Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Implantable Heart Failure Devices in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Implantable Heart Failure Devices Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Implantable Heart Failure Devices Market Dynamics
1.5.1 Implantable Heart Failure Devices Industry Trends
1.5.2 Implantable Heart Failure Devices Market Drivers
1.5.3 Implantable Heart Failure Devices Market Challenges
1.5.4 Implantable Heart Failure Devices Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Implantable Heart Failure Devices by Type
2.1 Implantable Heart Failure Devices Market by Type
2.1.1 Mechanical Assistance Type
2.1.2 Electrical Related Technology
2.1.3 Structural Improvement Type
2.2 Global Implantable Heart Failure Devices Market Size by Type
2.2.1 Global Implantable Heart Failure Devices Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Implantable Heart Failure Devices Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Implantable Heart Failure Devices Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Implantable Heart Failure Devices Market Size by Type
2.3.1 United States Implantable Heart Failure Devices Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Implantable Heart Failure Devices Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Implantable Heart Failure Devices Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Implantable Heart Failure Devices by Application
3.1 Implantable Heart Failure Devices Market by Application
3.1.1 GradeⅠ- Ⅳ
3.1.2 Grade Ⅱ- Ⅳ
3.1.3 Grade Ⅲ -IV
3.2 Global Implantable Heart Failure Devices Market Size by Application
3.2.1 Global Implantable Heart Failure Devices Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Implantable Heart Failure Devices Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Implantable Heart Failure Devices Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Implantable Heart Failure Devices Market Size by Application
3.3.1 United States Implantable Heart Failure Devices Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Implantable Heart Failure Devices Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Implantable Heart Failure Devices Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Implantable Heart Failure Devices Competitor Landscape by Company
4.1 Global Implantable Heart Failure Devices Market Size by Company
4.1.1 Global Key Manufacturers of Implantable Heart Failure Devices, Ranked by Revenue (2023)
4.1.2 Global Implantable Heart Failure Devices Revenue by Manufacturer (2019-2024)
4.1.3 Global Implantable Heart Failure Devices Sales by Manufacturer (2019-2024)
4.1.4 Global Implantable Heart Failure Devices Price by Manufacturer (2019-2024)
4.2 Global Implantable Heart Failure Devices Concentration Ratio (CR)
4.2.1 Implantable Heart Failure Devices Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Implantable Heart Failure Devices in 2023
4.2.3 Global Implantable Heart Failure Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Implantable Heart Failure Devices, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Implantable Heart Failure Devices, Product Offered and Application
4.5 Global Key Manufacturers of Implantable Heart Failure Devices, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Implantable Heart Failure Devices Market Size by Company
4.7.1 Key Players of Implantable Heart Failure Devices in United States, Ranked by Revenue (2023)
4.7.2 United States Implantable Heart Failure Devices Revenue by Players (2019-2024)
4.7.3 United States Implantable Heart Failure Devices Sales by Players (2019-2024)
5 Global Implantable Heart Failure Devices Market Size by Region
5.1 Global Implantable Heart Failure Devices Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Implantable Heart Failure Devices Market Size in Volume by Region (2019-2030)
5.2.1 Global Implantable Heart Failure Devices Sales in Volume by Region: 2019-2024
5.2.2 Global Implantable Heart Failure Devices Sales in Volume Forecast by Region (2025-2030)
5.3 Global Implantable Heart Failure Devices Market Size in Value by Region (2019-2030)
5.3.1 Global Implantable Heart Failure Devices Sales in Value by Region: 2019-2024
5.3.2 Global Implantable Heart Failure Devices Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Implantable Heart Failure Devices Market Size YoY Growth 2019-2030
6.2 Americas Implantable Heart Failure Devices Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Implantable Heart Failure Devices Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Implantable Heart Failure Devices Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Implantable Heart Failure Devices Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Implantable Heart Failure Devices Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Implantable Heart Failure Devices Market Size YoY Growth 2019-2030
7.2 EMEA Implantable Heart Failure Devices Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Implantable Heart Failure Devices Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Implantable Heart Failure Devices Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Implantable Heart Failure Devices Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Implantable Heart Failure Devices Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Implantable Heart Failure Devices Market Size YoY Growth 2019-2030
8.2 China Implantable Heart Failure Devices Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Implantable Heart Failure Devices Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Implantable Heart Failure Devices Market Size YoY Growth 2019-2030
9.2 APAC Implantable Heart Failure Devices Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Implantable Heart Failure Devices Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Implantable Heart Failure Devices Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Implantable Heart Failure Devices Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Implantable Heart Failure Devices Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Description and Business Overview
10.1.3 Abbott Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Abbott Implantable Heart Failure Devices Products Offered
10.1.5 Abbott Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Description and Business Overview
10.2.3 Medtronic Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Medtronic Implantable Heart Failure Devices Products Offered
10.2.5 Medtronic Recent Development
10.3 Jarvik Heart
10.3.1 Jarvik Heart Company Information
10.3.2 Jarvik Heart Description and Business Overview
10.3.3 Jarvik Heart Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Jarvik Heart Implantable Heart Failure Devices Products Offered
10.3.5 Jarvik Heart Recent Development
10.4 Abiomed
10.4.1 Abiomed Company Information
10.4.2 Abiomed Description and Business Overview
10.4.3 Abiomed Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Abiomed Implantable Heart Failure Devices Products Offered
10.4.5 Abiomed Recent Development
10.5 Boston Scientific
10.5.1 Boston Scientific Company Information
10.5.2 Boston Scientific Description and Business Overview
10.5.3 Boston Scientific Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Boston Scientific Implantable Heart Failure Devices Products Offered
10.5.5 Boston Scientific Recent Development
10.6 Impulse Dynamics
10.6.1 Impulse Dynamics Company Information
10.6.2 Impulse Dynamics Description and Business Overview
10.6.3 Impulse Dynamics Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.6.4 Impulse Dynamics Implantable Heart Failure Devices Products Offered
10.6.5 Impulse Dynamics Recent Development
10.7 SynCardia
10.7.1 SynCardia Company Information
10.7.2 SynCardia Description and Business Overview
10.7.3 SynCardia Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.7.4 SynCardia Implantable Heart Failure Devices Products Offered
10.7.5 SynCardia Recent Development
10.8 Berlin Heart
10.8.1 Berlin Heart Company Information
10.8.2 Berlin Heart Description and Business Overview
10.8.3 Berlin Heart Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.8.4 Berlin Heart Implantable Heart Failure Devices Products Offered
10.8.5 Berlin Heart Recent Development
10.9 Covia Medica
10.9.1 Covia Medica Company Information
10.9.2 Covia Medica Description and Business Overview
10.9.3 Covia Medica Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Covia Medica Implantable Heart Failure Devices Products Offered
10.9.5 Covia Medica Recent Development
10.10 V-Wave
10.10.1 V-Wave Company Information
10.10.2 V-Wave Description and Business Overview
10.10.3 V-Wave Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.10.4 V-Wave Implantable Heart Failure Devices Products Offered
10.10.5 V-Wave Recent Development
10.11 Evaheart
10.11.1 Evaheart Company Information
10.11.2 Evaheart Description and Business Overview
10.11.3 Evaheart Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.11.4 Evaheart Implantable Heart Failure Devices Products Offered
10.11.5 Evaheart Recent Development
10.12 BrioHealth Solutions
10.12.1 BrioHealth Solutions Company Information
10.12.2 BrioHealth Solutions Description and Business Overview
10.12.3 BrioHealth Solutions Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.12.4 BrioHealth Solutions Implantable Heart Failure Devices Products Offered
10.12.5 BrioHealth Solutions Recent Development
10.13 Hanyu Medical
10.13.1 Hanyu Medical Company Information
10.13.2 Hanyu Medical Description and Business Overview
10.13.3 Hanyu Medical Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.13.4 Hanyu Medical Implantable Heart Failure Devices Products Offered
10.13.5 Hanyu Medical Recent Development
10.14 NewMed Medical
10.14.1 NewMed Medical Company Information
10.14.2 NewMed Medical Description and Business Overview
10.14.3 NewMed Medical Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.14.4 NewMed Medical Implantable Heart Failure Devices Products Offered
10.14.5 NewMed Medical Recent Development
10.15 Valgen Medtech
10.15.1 Valgen Medtech Company Information
10.15.2 Valgen Medtech Description and Business Overview
10.15.3 Valgen Medtech Implantable Heart Failure Devices Sales, Revenue and Gross Margin (2019-2024)
10.15.4 Valgen Medtech Implantable Heart Failure Devices Products Offered
10.15.5 Valgen Medtech Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Implantable Heart Failure Devices Industry Chain Analysis
11.2 Implantable Heart Failure Devices Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Implantable Heart Failure Devices Production Mode & Process
11.4 Implantable Heart Failure Devices Sales and Marketing
11.4.1 Implantable Heart Failure Devices Sales Channels
11.4.2 Implantable Heart Failure Devices Distributors
11.5 Implantable Heart Failure Devices Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 159
USD 4900.00
(Single User License)
The global Implantable Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 92
USD 4250.00
(Single User License)
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 119
USD 3950.00
(Single User License)
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 120
USD 2900.00
(Single User License)
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 153
USD 4900.00
(Single User License)
The global Implantable Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 91
USD 4250.00
(Single User License)
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 3950.00
(Single User License)
The global market for Implantable Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 92
USD 2900.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 151
USD 4900.00
(Single User License)
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 159
The global Implantable Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 92
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 119
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 120
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 153
The global Implantable Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 91
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
The global market for Implantable Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 92
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 151
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now